Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease

T. Hibi, M. Ohara, K. Kobayashi, W. R. Brown, K. Toda, H. Takaishi, Y. Hosoda, A. Hayashi, Y. Iwao, M. Watanabe, Sadakazu Aiso, Y. Kawai, M. Tsuchiya

研究成果: Article

45 引用 (Scopus)

抄録

Circulating anti-goblet cell antibody and its corresponding antigen in patients with inflammatory bowel disease were investigated. Antigoblet cell antibody in the serum was examined by immunocytochemistry and enzyme linked immunosorbent assay (ELISA), using a colonic cancer cell line, HT29-18-N2, which differentiates into intestinal goblet cells. The frequencies of anti-goblet cell antibody detected by immunocytochemistry were 14 in 48 patients with ulcerative colitis (29%) and five in 15 patients with Crohn's disease (33%). By ELISA, the frequencies of anti-goblet cell antibody were 38% in ulcerative colitis and 33% in Crohn's disease. This antibody did not relate directly to anti-neutrophil cytoplasmic antibodies (ANCA), although the serum samples positive for anti-goblet cell antibody were commonly positive for ANCA in ulcerative colitis. Immunoprecipitation and SDS polyacrylamide gel electrophoresis (PAGE) study showed that the antibody in the ELISA positive serum samples recognised a >200 kD goblet cell antigen, which remained unchanged after reduction, indicating that it consists of single chain polypeptides. These results suggest that there is a subgroup of inflammatory bowel disease that has circulating anti-goblet cell antibody reactive with a >200 kD antigen. The antibody detected by newly established ELISA will be a disease marker for this group and the identification of the corresponding antigens may be important for the understanding of the underlying immune abnormalities.

元の言語English
ページ(範囲)224-230
ページ数7
ジャーナルGut
35
発行部数2
DOI
出版物ステータスPublished - 1994 1 1
外部発表Yes

ASJC Scopus subject areas

  • Gastroenterology

これを引用

Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease. / Hibi, T.; Ohara, M.; Kobayashi, K.; Brown, W. R.; Toda, K.; Takaishi, H.; Hosoda, Y.; Hayashi, A.; Iwao, Y.; Watanabe, M.; Aiso, Sadakazu; Kawai, Y.; Tsuchiya, M.

:: Gut, 巻 35, 番号 2, 01.01.1994, p. 224-230.

研究成果: Article

Hibi, T, Ohara, M, Kobayashi, K, Brown, WR, Toda, K, Takaishi, H, Hosoda, Y, Hayashi, A, Iwao, Y, Watanabe, M, Aiso, S, Kawai, Y & Tsuchiya, M 1994, 'Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease', Gut, 巻. 35, 番号 2, pp. 224-230. https://doi.org/10.1136/gut.35.2.224
Hibi, T. ; Ohara, M. ; Kobayashi, K. ; Brown, W. R. ; Toda, K. ; Takaishi, H. ; Hosoda, Y. ; Hayashi, A. ; Iwao, Y. ; Watanabe, M. ; Aiso, Sadakazu ; Kawai, Y. ; Tsuchiya, M. / Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease. :: Gut. 1994 ; 巻 35, 番号 2. pp. 224-230.
@article{1b900f3ad893448da860710288e2ae10,
title = "Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease",
abstract = "Circulating anti-goblet cell antibody and its corresponding antigen in patients with inflammatory bowel disease were investigated. Antigoblet cell antibody in the serum was examined by immunocytochemistry and enzyme linked immunosorbent assay (ELISA), using a colonic cancer cell line, HT29-18-N2, which differentiates into intestinal goblet cells. The frequencies of anti-goblet cell antibody detected by immunocytochemistry were 14 in 48 patients with ulcerative colitis (29{\%}) and five in 15 patients with Crohn's disease (33{\%}). By ELISA, the frequencies of anti-goblet cell antibody were 38{\%} in ulcerative colitis and 33{\%} in Crohn's disease. This antibody did not relate directly to anti-neutrophil cytoplasmic antibodies (ANCA), although the serum samples positive for anti-goblet cell antibody were commonly positive for ANCA in ulcerative colitis. Immunoprecipitation and SDS polyacrylamide gel electrophoresis (PAGE) study showed that the antibody in the ELISA positive serum samples recognised a >200 kD goblet cell antigen, which remained unchanged after reduction, indicating that it consists of single chain polypeptides. These results suggest that there is a subgroup of inflammatory bowel disease that has circulating anti-goblet cell antibody reactive with a >200 kD antigen. The antibody detected by newly established ELISA will be a disease marker for this group and the identification of the corresponding antigens may be important for the understanding of the underlying immune abnormalities.",
author = "T. Hibi and M. Ohara and K. Kobayashi and Brown, {W. R.} and K. Toda and H. Takaishi and Y. Hosoda and A. Hayashi and Y. Iwao and M. Watanabe and Sadakazu Aiso and Y. Kawai and M. Tsuchiya",
year = "1994",
month = "1",
day = "1",
doi = "10.1136/gut.35.2.224",
language = "English",
volume = "35",
pages = "224--230",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease

AU - Hibi, T.

AU - Ohara, M.

AU - Kobayashi, K.

AU - Brown, W. R.

AU - Toda, K.

AU - Takaishi, H.

AU - Hosoda, Y.

AU - Hayashi, A.

AU - Iwao, Y.

AU - Watanabe, M.

AU - Aiso, Sadakazu

AU - Kawai, Y.

AU - Tsuchiya, M.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Circulating anti-goblet cell antibody and its corresponding antigen in patients with inflammatory bowel disease were investigated. Antigoblet cell antibody in the serum was examined by immunocytochemistry and enzyme linked immunosorbent assay (ELISA), using a colonic cancer cell line, HT29-18-N2, which differentiates into intestinal goblet cells. The frequencies of anti-goblet cell antibody detected by immunocytochemistry were 14 in 48 patients with ulcerative colitis (29%) and five in 15 patients with Crohn's disease (33%). By ELISA, the frequencies of anti-goblet cell antibody were 38% in ulcerative colitis and 33% in Crohn's disease. This antibody did not relate directly to anti-neutrophil cytoplasmic antibodies (ANCA), although the serum samples positive for anti-goblet cell antibody were commonly positive for ANCA in ulcerative colitis. Immunoprecipitation and SDS polyacrylamide gel electrophoresis (PAGE) study showed that the antibody in the ELISA positive serum samples recognised a >200 kD goblet cell antigen, which remained unchanged after reduction, indicating that it consists of single chain polypeptides. These results suggest that there is a subgroup of inflammatory bowel disease that has circulating anti-goblet cell antibody reactive with a >200 kD antigen. The antibody detected by newly established ELISA will be a disease marker for this group and the identification of the corresponding antigens may be important for the understanding of the underlying immune abnormalities.

AB - Circulating anti-goblet cell antibody and its corresponding antigen in patients with inflammatory bowel disease were investigated. Antigoblet cell antibody in the serum was examined by immunocytochemistry and enzyme linked immunosorbent assay (ELISA), using a colonic cancer cell line, HT29-18-N2, which differentiates into intestinal goblet cells. The frequencies of anti-goblet cell antibody detected by immunocytochemistry were 14 in 48 patients with ulcerative colitis (29%) and five in 15 patients with Crohn's disease (33%). By ELISA, the frequencies of anti-goblet cell antibody were 38% in ulcerative colitis and 33% in Crohn's disease. This antibody did not relate directly to anti-neutrophil cytoplasmic antibodies (ANCA), although the serum samples positive for anti-goblet cell antibody were commonly positive for ANCA in ulcerative colitis. Immunoprecipitation and SDS polyacrylamide gel electrophoresis (PAGE) study showed that the antibody in the ELISA positive serum samples recognised a >200 kD goblet cell antigen, which remained unchanged after reduction, indicating that it consists of single chain polypeptides. These results suggest that there is a subgroup of inflammatory bowel disease that has circulating anti-goblet cell antibody reactive with a >200 kD antigen. The antibody detected by newly established ELISA will be a disease marker for this group and the identification of the corresponding antigens may be important for the understanding of the underlying immune abnormalities.

UR - http://www.scopus.com/inward/record.url?scp=0028219482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028219482&partnerID=8YFLogxK

U2 - 10.1136/gut.35.2.224

DO - 10.1136/gut.35.2.224

M3 - Article

C2 - 8307474

AN - SCOPUS:0028219482

VL - 35

SP - 224

EP - 230

JO - Gut

JF - Gut

SN - 0017-5749

IS - 2

ER -